Regardless of the method of integration and the chosen combination of product and metabolic engineering genes, it is desirable to manipulate the cell in a minimal number of steps. This goal is addressed by technology for simultaneous cloning and subsequent expression of multiple genes in a desired host. Besides providing a platform for future metabolic engineering breakthroughs, multicistronic expression technology should speed basic functional genomic research and new applications in tissue engineering and gene therapy.